All terms in GO
| Label | Id | Description |
|---|---|---|
| PTEX complex | GO_0097619 |
A protein complex that acts as a protein trafficking machinery and is responsible for the export of proteins across the parasitophorous (symbiont-containing) vacuolar membrane and into the human host cell. The PTEX complex is located in the vacuole membrane. It is ATP-powered, and comprises heat shock protein 101 (HSP101; a ClpA/B-like ATPase from the AAA+ superfamily, of a type commonly associated with protein translocons), a parasite protein termed PTEX150, and exported protein 2 (EXP2). EXP2 is the potential channel, as it is the membrane-associated component of the core PTEX complex. Two other proteins, PTEX88 and thioredoxin 2 (TRX2), were also identified as PTEX components.
|
| negative regulation of meiotic spindle elongation | GO_1902120 |
Any process that stops, prevents or reduces the frequency, rate or extent of meiotic spindle elongation.
|
| negative regulation of meiotic nuclear division | GO_0045835 |
Any process that stops, prevents, or reduces the frequency, rate or extent of meiosis.
|
| lithocholic acid binding | GO_1902121 |
Binding to lithocholic acid.
|
| bile acid binding | GO_0032052 |
Binding to a bile acid, a steroid carboxylic acids occurring in bile.
|
| chenodeoxycholic acid binding | GO_1902122 |
Binding to chenodeoxycholic acid.
|
| (-)-pinoresinol catabolic process | GO_1902123 |
The chemical reactions and pathways resulting in the breakdown of (-)-pinoresinol.
|
| (-)-pinoresinol metabolic process | GO_1901598 |
The chemical reactions and pathways involving (-)-pinoresinol.
|
| (+)-pinoresinol metabolic process | GO_1902124 |
The chemical reactions and pathways involving (+)-pinoresinol.
|
| (+)-pinoresinol catabolic process | GO_1902125 |
The chemical reactions and pathways resulting in the breakdown of (+)-pinoresinol.
|
| (+)-pinoresinol biosynthetic process | GO_1902126 |
The chemical reactions and pathways resulting in the formation of (+)-pinoresinol.
|
| (-)-lariciresinol metabolic process | GO_1902127 |
The chemical reactions and pathways involving (-)-lariciresinol.
|
| (-)-lariciresinol catabolic process | GO_1902128 |
The chemical reactions and pathways resulting in the breakdown of (-)-lariciresinol.
|
| (-)-lariciresinol biosynthetic process | GO_1902129 |
The chemical reactions and pathways resulting in the formation of (-)-lariciresinol.
|
| (R)-mandelate dehydrogenase activity | GO_0097620 |
Catalysis of the reaction: (R)-2-hydroxy-2-phenylacetate + acceptor = phenylglyoxylate + reduced acceptor.
|
| monoamine oxidase activity | GO_0097621 |
Catalysis of the reaction: RCH2NHR' + H2O + O2 = RCHO + R'NH2 + H2O2.
|
| oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor | GO_0016641 |
Catalysis of an oxidation-reduction (redox) reaction in which a CH-NH2 group acts as a hydrogen or electron donor and reduces an oxygen molecule.
|
| cytoplasmic translational elongation through polyproline stretches | GO_0097622 |
The successive addition of amino acid residues to a nascent polypeptide chain, proceeding through regions of multiple repeated proline codons, during protein biosynthesis in the cytoplasm.
|
| cytoplasmic translational elongation | GO_0002182 |
The successive addition of amino acid residues to a nascent polypeptide chain during protein biosynthesis in the cytoplasm.
|
| potassium ion export across plasma membrane | GO_0097623 |
The directed movement of potassium ions from inside of a cell, across the plasma membrane and into the extracellular region.
|